Intelliheart tests in Amcal pharmacies

By Dylan Bushell-Embling
Friday, 13 June, 2008

IM Medical (ASX: IMI) has reached an exclusive agreement with Sigma Pharmaceuticals that will see the Intelliheart cardiac risk assessment tests sold through Sigma's Amcal network.

The Amcal network includes over 700 Amcal, Amcal Max and Guardian pharmacies throughout the country.

The product will initially be rolled out to over 200 pharmacies throughout Victoria in July. Stores in other states will begin stocking the product in the next few months.

Under the agreement Sigma has the right to produce and market other products using the Intelliheart brand name.

Intelliheart is the only widely available diagnostic which tests for both heart rate variability and arterial stiffness.

Related News

'Mini brains' mimic MS myelin damage

The MS organoids give researchers a highly detailed cellular view of myelin destruction...

Fast-aging placentas may contribute to pre-eclampsia

Placentas affected by pre-eclampsia show several signs of accelerated aging, including increased...

BioNTech opens mRNA manufacturing facility at La Trobe

Offering state-subsidised access to researchers and biotech startups, the facility aims to enable...


  • All content Copyright © 2026 Westwick-Farrow Pty Ltd